I-DireCT

Immune DIREcted and Cancer-selective immunoTherapy

Programm
Horizon 2020 & sub-programmes
Innovationsökosystem
Health
Laufzeit
57 Monate (January 2019 – September 2023)
Projektförderung
≈ €3 million
Projektpartner
5

Worum es geht

I-DireCT is a European Industrial Doctorate (EID) training network designed to provide training and carry out breakthrough research on the rapidly expanding and high impact field of cancer immunotherapy in a carefully integrated academic and inter-sectoral programme. Hereby, the consortium aims to develop next-generation immunotherapeutics and deliver a set of early stage researchers uniquely qualified for a career in academia and/or industry.

Koordination

Prof. Edwin Bremer

Academisch Ziekenhuis Groningen

E-Mail senden

Ihr EURICE-
Kontakt

Ihr Kontakt
Marina Lorenz
Project Manager
E-mail

Explore THE COURT

Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.

THE COURT betreten